Management of nonobstructive idiopathic feline lower urinary tract disease.
Consistently effective treatment and prevention of nonobstructive idiopathic lower urinary tract disease (LUTD) in male and female cats remains an enigma. Because clinical signs associated with this form are frequently self-limiting, considerable debate exists about the efficacy of various symptomatic therapies advocated for management of idiopathic feline LUTD. Any form of therapy might appear to be beneficial, as long as it was not harmful. The self-limiting nature of some forms of idiopathic feline LUTD underscores the need for controlled prospective double-blind clinical studies to prove the value of various forms of therapy.
Kruger
J M
JM
Department of Small Animal Clinical Sciences, College of Veterinary Medicine, East Lansing, Michigan, USA.
Osborne
C A
CA
Lulich
J P
JP
D000700:Analgesics / Q000627:therapeutic use*; D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000892:Anti-Infective Agents, Urinary / Q000627:therapeutic use*; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D002371:Cat Diseases / Q000188:drug therapy* / Q000453:epidemiology / Q000209:etiology; D002415:Cats; D005260:Female; D008297:Male; D010276:Parasympatholytics / Q000627:therapeutic use*; D014570:Urologic Diseases / Q000188:drug therapy / Q000453:epidemiology / Q000662:veterinary*
D000700:Analgesics; D000900:Anti-Bacterial Agents; D000892:Anti-Infective Agents, Urinary; D000893:Anti-Inflammatory Agents; D010276:Parasympatholytics